OREX Key Stats
|Revenue (Quarterly YoY Growth)||0.00%|
|EPS Diluted (TTM)||-1.001|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-88.64M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)||-2167%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- 3 Horrendous Health-Care Stocks This Week Fool Dec 7
- Arena Pharmaceuticals' Slow 2013 Fool Dec 6
- Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes noodls Dec 6
- Will These Drugmakers Profit From Patient Weight Loss? Fool Dec 4
- Biotech Stock Roundup: CBST Hits 52-Week High, OREX Lights Up - Analyst Blog Zacks Dec 4
- Orexigen Therapeutics' CEO presents at Piper Jaffray 2013 Healthcare Conference (Transcript) Seeking Alpha Dec 3
- Orexigen Therapeutics (OREX) Prices $100M Convertible Notes Offering Street Insider Dec 3
- Orexigen Therapeutics, Inc. Prices Offering of $100 Million of Convertible Senior Notes PR Newswire Dec 3
- This New Data Shows We're on the Wrong Path to Treating Obesity Fool Dec 2
- Orexigen Announces $100 Million Offering Seeking Alpha Dec 2
OREX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Orexigen Therapeutics is up 18.88% over the last year vs S&P 500 Total Return up 30.43%, Arena Pharmaceuticals down 31.61%, and Vivus down 9.82%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for OREX
Pro Report PDF for OREX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download OREX Pro Report PDF
Pro Strategies Featuring OREX
Did Orexigen Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Orexigen Therapeutics, Inc., is a biopharmaceutical company. The Company is engaged in development of pharmaceutical product candidates for the treatment of obesity. Its product candidate includes: Contrave & Empatic.